sertraline has been researched along with Pervasive Child Development Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vitiello, B | 1 |
| Ghanizadeh, A | 1 |
| Barbosa, V; Ghaziuddin, M; Ghaziuddin, N; Gih, D; Maixner, DF | 1 |
| Chiu, S; Hagerman, R; Hendren, R; Hessl, D; Solomon, M | 1 |
| Ozbayrak, KR | 1 |
| Brodkin, ES; Carlson, DC; Cohen, DJ; McDougle, CJ; Naylor, ST; Price, LH | 1 |
| Ghaziuddin, N; Iqbal, A; Khetarpal, S | 1 |
1 trial(s) available for sertraline and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.
Topics: 1-Naphthylamine; Adolescent; Adult; Aggression; Child Development Disorders, Pervasive; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
6 other study(ies) available for sertraline and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Should tactile sensation impairment be considered in pharmacotherapy of pervasive developmental disorders? A case report.
Topics: Adult; Antidepressive Agents; Asperger Syndrome; Child; Child Development Disorders, Pervasive; Depressive Disorder, Major; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Touch Perception; Treatment Outcome | 2008 |
Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents.
Topics: Adolescent; Age of Onset; Aggression; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Autistic Disorder; Catatonia; Child; Child Development Disorders, Pervasive; Education, Special; Electroconvulsive Therapy; Electroencephalography; Fluoxetine; Hearing Loss, Sensorineural; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Puberty; Sertraline; Sports; Stereotyped Behavior | 2010 |
A genetic etiology of pervasive developmental disorder guides treatment.
Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Comorbidity; Female; Fragile X Syndrome; Humans; Occupational Therapy; Phenotype; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Sertraline in PDD.
Topics: 1-Naphthylamine; Adolescent; Child; Child Development Disorders, Pervasive; Humans; Male; Sertraline | 1997 |
Myoclonus during prolonged treatment with sertraline in an adolescent patient.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonazepam; Female; Humans; Methylphenidate; Myoclonus; Pseudotumor Cerebri; Risk Factors; Sertraline | 2001 |